Los Angeles Capital Management LLC Acadia Pharmaceuticals Inc Transaction History

Los Angeles Capital Management LLC

$27.9 Billion
Q2 2024

A detailed history of Los Angeles Capital Management LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 50,969 shares of ACAD stock, worth $753,831. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,969

Previous 67,474 24.46%

Holding current value

$753,831

Previous $1.25 Million 33.6%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$14.62 - $18.42 $241,303 - $304,022	-16,505 Reduced 24.46%	50,969 $828,000
Q1 2024 Apr 05, 2024	BUY	$17.79 - $30.86 $40,828 - $70,823	2,295 Added 3.52%	67,474 $1.25 Million
Q4 2023 Feb 06, 2024	BUY	$20.78 - $31.77 $412,919 - $631,301	19,871 Added 43.86%	65,179 $2.04 Million
Q3 2023 Nov 06, 2023	BUY	$20.84 - $33.47 $78,587 - $126,215	3,771 Added 9.08%	45,308 $944,000
Q2 2023 Aug 03, 2023	BUY	$17.8 - $25.65 $286,455 - $412,785	16,093 Added 63.25%	41,537 $994,000
Q1 2023 May 04, 2023	BUY	$16.32 - $20.92 $415,246 - $532,288	25,444 New	25,444 $478,000
Q2 2021 Aug 05, 2021	SELL	$19.4 - $27.42 $319,285 - $451,278	-16,458 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$25.02 - $54.99 $614,991 - $1.35 Million	-24,580 Reduced 59.9%	16,458 $0
Q4 2020 Feb 04, 2021	SELL	$41.04 - $56.79 $206,226 - $285,369	-5,025 Reduced 10.91%	41,038 $2.19 Million
Q3 2020 Nov 02, 2020	SELL	$36.42 - $57.0 $1.15 Million - $1.8 Million	-31,641 Reduced 40.72%	46,063 $1.9 Million
Q2 2020 Aug 05, 2020	BUY	$39.26 - $52.73 $485,803 - $652,481	12,374 Added 18.94%	77,704 $0
Q1 2020 May 04, 2020	BUY	$31.65 - $46.87 $642,400 - $951,320	20,297 Added 45.07%	65,330 $2.76 Million
Q4 2019 Feb 07, 2020	BUY	$36.21 - $51.4 $129,414 - $183,703	3,574 Added 8.62%	45,033 $1.93 Million
Q3 2019 Nov 07, 2019	BUY	$22.22 - $44.01 $571,920 - $1.13 Million	25,739 Added 163.73%	41,459 $1.49 Million
Q2 2019 Jul 29, 2019	SELL	$23.32 - $28.12 $404,019 - $487,179	-17,325 Reduced 52.43%	15,720 $420,000
Q1 2019 Apr 25, 2019	BUY	$16.17 - $27.38 $534,337 - $904,772	33,045 New	33,045 $887,000
Q3 2018 Nov 05, 2018	SELL	$13.03 - $21.81 $5.87 Million - $9.82 Million	-450,345 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$15.07 - $22.34 $6.79 Million - $10.1 Million	450,345 New	450,345 $6.88 Million

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Acadia Pharmaceuticals Inc Transaction History